85 related articles for article (PubMed ID: 28691211)
1. Comprehensive profiling of H-Ras signalling in angiosarcoma endothelium.
da Costa A; Bonner M; Arbiser JL
Clin Exp Dermatol; 2017 Aug; 42(6):645-647. PubMed ID: 28691211
[TBL] [Abstract][Full Text] [Related]
2. IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.
Taylor KL; Oates RK; Grane R; Leaman DW; Borden EC; Lindner DJ
J Interferon Cytokine Res; 2006 May; 26(5):353-61. PubMed ID: 16689662
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.
Tamburini BA; Phang TL; Fosmire SP; Scott MC; Trapp SC; Duckett MM; Robinson SR; Slansky JE; Sharkey LC; Cutter GR; Wojcieszyn JW; Bellgrau D; Gemmill RM; Hunter LE; Modiano JF
BMC Cancer; 2010 Nov; 10():619. PubMed ID: 21062482
[TBL] [Abstract][Full Text] [Related]
4. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of a linkage between H-Ras and MMP-13 expression as well as MMP-9 by chemical genomic approach.
Lee SK; Kim JM; Lee MY; Son KH; Yeom YI; Kim CH; Shin Y; Koh JS; Han DC; Kwon BM
Int J Cancer; 2006 May; 118(9):2172-81. PubMed ID: 16331612
[TBL] [Abstract][Full Text] [Related]
6. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
7. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
Wisdom R; Huynh L; Hsia D; Kim S
Oncogene; 2005 Oct; 24(47):7043-54. PubMed ID: 16007133
[TBL] [Abstract][Full Text] [Related]
8. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB
Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profile of Ki-Ras-induced transformation of thyroid cells.
Visconti R; Federico A; Coppola V; Pentimalli F; Berlingieri MT; Pallante P; Kruhoffer M; Orntoft TF; Fusco A
Cancer Invest; 2007 Jun; 25(4):256-66. PubMed ID: 17612936
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice.
Dill MT; Rothweiler S; Djonov V; Hlushchuk R; Tornillo L; Terracciano L; Meili-Butz S; Radtke F; Heim MH; Semela D
Gastroenterology; 2012 Apr; 142(4):967-977.e2. PubMed ID: 22245843
[TBL] [Abstract][Full Text] [Related]
13. Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
[TBL] [Abstract][Full Text] [Related]
14. FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts.
Kakumoto K; Sasai K; Sukezane T; Oneyama C; Ishimaru S; Shibutani K; Mizushima H; Mekada E; Hanafusa H; Akagi T
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5490-5. PubMed ID: 16569692
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
17. Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation.
Ikonomou G; Kostourou V; Shirasawa S; Sasazuki T; Samiotaki M; Panayotou G
J Proteomics; 2012 Sep; 75(17):5356-69. PubMed ID: 22800643
[TBL] [Abstract][Full Text] [Related]
18. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.
Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J
Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059
[TBL] [Abstract][Full Text] [Related]
19. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
